Jean-Sebastien Steffen

Apr 23, 2024 | drugdiscoveryonline.com | Steve Fawell |Jean-Sebastien Steffen |Dan Bowles

Progress with PROTACs and molecular glues hasn’t come without challenges, particularly in identifying the right chemistry starting point for drug development — a process known as hit discovery. This article looks at the role of CRISPR, screening assays, and more.

Apr 12, 2024 | bioprocessonline.com | Nathan Parker |Claus Exenberger |Jean-Sebastien Steffen |Ian Burdick

The introduction of ICH Q14 to analytical procedure development provides guidance on the recommended approach to assay development and the justifications regulatory bodies require to demonstrate the development of a method. While applying an AQbD approach may require more upfront work, the advantages are a better understood and more robust method, with greater regulatory flexibility.

Apr 11, 2024 | pharmaceuticalonline.com | Jean-Sebastien Steffen |James Mackenzie

Visit METTLER TOLEDO in booth 2361 at Interphex New York, April 15-18th! See live demonstrations of product inspection solutions for the pharmaceutical industry! Showcased systems include a combination vision/checkweigher, new metal detection systems, and the latest X-ray inspection system. You can also learn about how ProdX data management software can improve product safety and increase production efficiencies while ensuring regulatory compliance.

Apr 1, 2024 | outsourcedpharma.com | Kamil Shaik |Guriqbal Singh |Jean-Sebastien Steffen |Ann McMahon |Louis Garguilo

Webinar: De-Risking The Aseptic Drug-Filling Process And Optimizing ProductionIn the aseptic drug-filling process for biotherapeutics, your company may find it challenging to meet regulatory compliance standards, putting the safety and effectiveness of your products at risk. Join us and gain valuable insights into enhancing the efficiency and reliability of the drug product manufacturing process.

Mar 5, 2024 | drugdeliveryleader.com | Jean-Sebastien Steffen |Primary Packaging

By Jean-Sebastien Steffen, Ph.D., Group Lead, Combination Products and Primary Packaging, Lonza Prefilled syringes (PFSs) offer significant advantages for both manufacturers and patients of biotherapeutics. For manufacturers, PFSs provide flexibility in accommodating different drug viscosities, volumes, and administration routes, enhancing their delivery options.